Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
NCT ID: NCT00116675
Last Updated: 2007-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
84 participants
INTERVENTIONAL
2005-03-31
2006-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A second purpose is to evaluate the safety of the drug.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
NCT00116662
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
NCT00115141
Study With a Topical Gel to Treat Common Warts in Adults
NCT00117923
Study With a Topical Gel to Treat Common Warts in Adults
NCT00117871
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
NCT00114920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resiquimod
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages between 3 to 11
Exclusion Criteria
* Currently participating in another clinical study
* Chronic viral hepatitis B or C
3 Years
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Graceway Pharmaceuticals, LLC
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas, United States
University of California - San Francisco
San Francisco, California, United States
Longmont Clinic/Longmont Medical Research Network
Longmont, Colorado, United States
Mercy Health Research
St Louis, Missouri, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Rhode Island Hospital - Jane Brown Building
Providence, Rhode Island, United States
DermResearch, Inc.
Austin, Texas, United States
Alpine Pediatrics
Pleasant Grove, Utah, United States
Walla Walla Clinic
Walla Walla, Washington, United States
Advanced Healthcare
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1535-RESI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.